The altered levels of these proteins indicated that sh-KLF3 suppressed the expression of GSK3β, resulting in increased concentrations of p-GSK3β(Ser9) and nuclear β-catenin, and reduced cytoplasmic β-catenin levels in CRC cells. The gene discussed is KLF3; the disease is colorectal carcinoma.